British Journal of Cancer

Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences. British Journal of Cancer (BJC) exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients. BJC works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.

Publisher
Nature Publishing Group
Country
United Kingdom
History
1947--present
Impact factor
6.176 (2016)
Some content from Wikipedia, licensed under CC BY-SA

Cytokine levels could predict immunotherapy problems

The development of immunotherapy, which mobilizes the body's own immune system to destroy cancer cells, is one of the greatest advances in cancer treatment, but immunotherapy can cause harm to healthy tissue in some patients. ...

Oct 31, 2018
popularity35 comments 0

Researchers developing test for early breast lesions

Currently, with a pre-malignant breast cancer diagnosis from a biopsy, there are three options: observation, chemoprevention or surgery, all of which require a patient to make decisions while operating from a place of fear ...

Oct 30, 2018
popularity18 comments 0